What we do

We study how the host adaptive immune response coevolves with pathogens, especially in ways relevant to epidemiological and evolutionary forecasting, vaccine design, and pathogen diversity. Our work is computational, and we collaborate closely with immunologists and epidemiologists.


Sarah weighs in on the new evidence for market origins in the New York Times.
March 18, 2023

In collaboration with the US Flu Vaccine Effectiveness Network and researchers at the CDC and Harvard School of Public Health, we report that repeat vaccination effects cannot be fully explained by clinical infection history or differences in the timing of vaccination between people---but influenza infections that are not medically attended might explain this puzzling phenomenon.
March 17, 2023

More news…